Taiwan clinicians found Accuray’s helical TomoTherapy feasible for accelerated partial breast irradiation, with low early toxicity in breast cancer treatment. T

Taiwan clinicians found Accuray’s helical TomoTherapy feasible for accelerated partial breast irradiation, with low early toxicity in breast cancer treatment. The retrospective analysis covered 16 plans, adding early clinical support for broader APBI use.